Factory 99% Dacarbazine Powder CAS 4342-03-4 Chemical Intermediate Dacarbazine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A912
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Dacarbazine
• CAS: 4342-03-4
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Dacarbazine
Appearance	White Powder
CAS NO.	4342-03-4
Storage	Keep in a cool, dry, dark location

 

Dacarbazine is a chemotherapy medication that belongs to the class of alkylating agents. It is primarily used in the treatment of certain types of cancers, particularly melanoma and Hodgkin's lymphoma.

 

1. Cancer Treatment: Dacarbazine is primarily applied in the therapeutic regimen for various cancers, including malignant melanoma, a type of skin cancer, and Hodgkin's lymphoma, a cancer of the lymphatic system. It works by interfering with the DNA replication process of rapidly dividing cancer cells, thereby inhibiting their growth and proliferation.

2. Combination Therapy: Often, dacarbazine is used in combination with other chemotherapy drugs to enhance its efficacy. This approach aims to target cancer cells from multiple angles, increasing the chances of successful treatment outcomes. The specific combination of drugs may vary depending on the type and stage of cancer being treated.

3. Adjuvant Therapy: In some cases, dacarbazine may be used as adjuvant therapy, which means it is administered after the primary treatment (such as surgery or radiation) to eliminate any remaining cancer cells and reduce the risk of recurrence.

1. DNA Alkylation: The primary function of dacarbazine is to alkylate DNA, a process that involves the addition of alkyl groups to DNA molecules. This disruption in DNA structure leads to cell death, particularly in rapidly dividing cancer cells.

2. Cell Cycle Arrest: By interfering with DNA replication, dacarbazine can cause cancer cells to arrest at specific points in the cell cycle, preventing them from progressing through normal cell division and ultimately leading to their death.

3. Immunomodulatory Effects: Some studies suggest that dacarbazine may also have immunomodulatory effects, although the exact mechanisms are not fully understood. These effects could potentially contribute to its anti-cancer activity by enhancing the immune system's ability to recognize and destroy cancer cells.